Artelo Biosciences Inc

NASDAQ:ARTL  
0.39
-0.04 (-9.17%)
Earnings Announcements

Artelo Biosciences Reports Fiscal 2021 Year-End Financial Results And Provides Business Update

Published: 11/29/2021 13:55 GMT
Artelo Biosciences Inc (ARTL) - Artelo Biosciences Reports Fiscal 2021 Year-end Financial Results and Provides Business Update.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.06

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.07

More details on our Analysts Page.